Biotechnology and Development ApS: Financial statements 2023
CVR: 33870639
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Biotechnology and Development ApS (CVR 33870639) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,977 and a net result of DKK -14,614 compared with DKK 19,043 the year before. That is a decrease of 93.3% compared with the year before. Equity in the 2023 report amounted to DKK 40,760. The solvency ratio was 52.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,977
- Profit/Loss
- DKK -14,614
- Equity
- DKK 40,760
- Total Assets
- DKK 77,667
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 3 t. | -15 t. | 41 t. | 1 |
| 2022 | - | 45 t. | 19 t. | 55 t. | 1 |
| 2021 | - | -7 t. | -22 t. | 36 t. | 1 |
| 2020 | - | 79 t. | 47 t. | 58 t. | 0 |
| 2019 | - | 19 t. | -8 t. | 12 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Biotechnology and Development ApS
Biotechnology and Development ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2011. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The management consists of Karl Erik Molbech. The company is owned by KLMC Holding ApS. The company has 1 employee (2018). In 2026, the company reported a gross profit of DKK 268,463 and a net result of DKK -54,610 compared with DKK -1,709 the year before. Equity in the 2026 report amounted to DKK 50,608.